Antimalarial substances found in New Caledonian sponges

July 21, 2004

Marine organisms synthesize many different substances, some of which possess anticarcinogenic, antiviral or antiparasitic properties. Only 1% of recorded marine species have had their chemical composition analysed. IRD scientists and their partners (1) have investigated the chemical structure of substances extracted from New Caledonian sponges. They demonstrated antimalarial activity in 25 members of the phloeodictine family of alkaloids, isolated from one of the species of shallow-water sponge present in lagoon. Laboratory tests showed these substances to be active against a chloroquine-resistant strain of Plasmodium falciparum, the pathological agent of malaria. These substances with hitherto unknown structures have potential as starting material for elaborating novel antimalarial medicines. Living organisms are an enormous reservoir of natural compounds potentially active against viruses, bacteria or cancerous cells, that could lead to the development of new medicines. Out of about 145 000 natural substances described today, 10% come from marine organisms. Among the few such organisms studied for their chemical composition, sponges of the genus Phloeodictyon (Haploscleridae) collected in shallow New Caledonian waters during campaigns of the programme "Marine Substances of Biological Interest" (SMIB), have proved to contain particular organic compounds, the phloeodictines, alkaloids with powerful antibacterial properties (2). Up to now, only deep-water species of Phloeodictyon were thought to synthesize these alkaloids, present in all the samples of such bathyal forms taken from an array of seamounts off the southern sector of New Caledonia. However, phloeodictines have recently been found in shallow-water Oceanapia (a taxonomic synonym of Phloeodictyon) species living on the reef off the east coast of New Caledonia, by a joint scientific team involving the IRD, the University of Trente (Italy), the CNRS and the industrial group Pierre Fabre. This discovery suggests a possible adaptation of bathyal species to the shallow-water reef environment.

The emergence of drug-resistant forms of the malarial agent Plasmodium falciparum has made essential a search for new compounds to control it. Scientists specialized in natural substances, investigating the chemical structure and properties of the phloeodictines as part of the French malaria control research programme Pal +, have revealed antimalarial activity among phloeodictines extracted from the reef sponge Oceanapia fistulosa.

The phloeodictines are a family of alkaloids, composed of three large groups distinguished according to differences in their chemical skeleton. They all carry a lateral poly-N chain and a variable-length carbon chain (3). Phloeodictines types B and C, which are minority compounds, carry an additional sulfurated poly-N chain. Smaller structural variations can occur in each of these three groups, in the lateral chains of variable length and degree of unsaturation, This makes for a highly complex chemical family. A combination of chromatographic and spectrometric methods obtained the characterization of 25 different compounds that belong to these three groups, extracted from Oceanapia fistulosa. Seventeen of them are new variants.

Laboratory tests involving presentation of a chloroquine-resistant strain of Plasmodium falciparum with these different components demonstrated low-dose inhibition of parasite development by type A phloeodictines, most of which were new.

A particularly promising feature of these phloeodictines' antimalarial action is that, in vitro, it is accompanied by very low cytotoxicity. These components therefore hold potential as material for the elaboration of antimalarial medicines with new types of structure. Other investigations are planned to seek confirmation of these results and find out accurate information on this antimalarial activity in vivo, using infected rodent models, and to attempt to unravel phloeodictines' action mechanism.
-end-
Marie Guillaume - IRD
Translation : Nicholas Flay

(1) The IRD, the CNRS and Pierre Fabre Laboratories are working together in research on new natural compounds with pharmacological potential. The research project on tropical antimalarial compounds, by rapid screening of the flora and flora, financed by the research programme Pal+, extends this partnership to INSERM and universities from industrialized countries and countries of the South.
(2) E. Kourany-Lefoll, C. Debitus et al., 1992 - Phloeodictines A and B : New Antibacterial and cytotoxic Bicyclic Amidinium Salts from the New Caledonian Sponge, Phloeodictyon sp., The Journal of Organic Chemistry 57, 3832-3835.
E. Kourany-Lefoll, C. Debitus et al., 1994 - Phloeodictines A1-A7 and C1-C2, Antibiotic and Cytotoxic Guanidine Alkaloids from the New Caledonian Sponge, Phloeodictyon sp. Tetrahedron 50 3415-3426.
(3) The phloeodictines have a side chain ending in a guanidine group and a carbon chain of variable length. Types B and C carry a supplementary thioethylguanidine side chain.

FOR FURTHER INFORMATION

CONTACTS
Cécile Debitus - UMR 152 " Pharmacochimie des substances naturelles et pharmacophores redox " IRD-UPS. Institut de Sciences et Technologies du Médicament de Toulouse, 3 rue des satellites, 31400 Toulouse, France, Tel. 33-534-321-408; Fax. 33-534-321-414 Email : cecile.debitus@ird.fr
or Michel Sauvain - UR 152 " Pharmacochimie des substances naturelles et pharmacophores redox " IRD-UPS. Faculté des Sciences Pharmaceutiques, 35 chemin des Maraîchers, 31062 Toulouse cedex 4, France. Tel.: 33-562-256-886, Fax: 33-562-256-852. Email : michel.sauvain@ird.fr

Institut de recherche pour le développement

Related Plasmodium Falciparum Articles from Brightsurf:

Malaria parasites adapt to survive the dry season, research shows
The main parasite that causes malaria can alter its gene expression to survive undetected in the human blood stream, new research has shown.

Malaria vaccines based on engineered parasites show safety, signs of efficacy
Two vaccines for malaria based on genetically engineered malaria parasites have been found to be safe in humans and show preliminary signs of protection, according to a pair of new phase 1/2a clinical trials.

How malaria parasites become resistant to artemisinin antimalarial drugs
Malaria parasite mutations that inhibit the endocytoic appetite for a host's red blood cells may render them resistant to artemisinin, a widely used frontline antimalarial drug, according to a new study, which reveals a key molecular mechanism of drug resistance.

A new breakthrough in developing effective antimalarial drugs
Parasites in the genus Plasmodium, which cause malaria, are transmitted to humans through bites from infected mosquitoes.

Resurrection of 50,000-year-old gene reveals how malaria jumped from gorillas to humans
For the first time, scientists have uncovered the likely series of events that led to the world's deadliest malaria parasite being able to jump from gorillas to humans.

Diversity of Plasmodium falciparum across Sub-Saharan Africa
Scientists from the Walter Reed Army Institute of Research joined a network of scientists to publish a study in Science to identify a regional character to Plasmodium falciparum across Africa.

RTS,S vaccine could favor the acquisition of natural immunity against malaria
The RTS,S malaria vaccine could enhance the production of protective antibodies upon subsequent parasite infection, according to a study led by the Barcelona Institute for Global Health (ISGlobal), an institution supported by 'la Caixa.' The results, published in BMC Medicine, identify the antigens (or protein fragments) that could be included in future, more effective multivalent vaccines.

Proteasome inhibitors show promise for drug-resistant malaria
Proteasome inhibitors have significant promise as components of novel combination therapies to treat multidrug-resistant malaria, according to a study published June 6 in the open-access journal PLOS Pathogens by David Fidock, Caroline Ng, and Barbara Stokes of Columbia University Irving Medical Center, Matthew Bogyo of Stanford University School of Medicine, and colleagues.

Parasites from patients with cerebral malaria stick preferentially in their brains
A team at LSTM with their collaborators in Malawi and Denmark have provided, for the first time, evidence which links the ability of red blood cells infected with the malaria parasite to bind to the cells lining the blood vessels of the brain, with the clinical syndrome cerebral malaria.

Pyronaridine-artesunate for treating uncomplicated Plasmodium falciparum malaria
Researchers from LSTM have looked at the efficacy of using a novel artemisinin-based combination therapy (ACT), pyronaridine-artesunate, to treat malaria in areas where resistance to other ACTs is becoming a problem.

Read More: Plasmodium Falciparum News and Plasmodium Falciparum Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.